Replies to post #477544 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

What does it tell you that management won't pay for their warrants???

That, unlike NVCR, NWBO management is not in a rush to cash out. That is a great point Scotty. NVCR is running scared while NWBO management is holding tight. That says a lot. This is what I'd expect from a bullish shareholder with an end of year $15 target price! (rounded)

Have a good one buddy.

[KevGee59]

She’s obviously making it work or NWBO wouldn’t be still be here.

[VikingInvest]

You do understand that until they release TLD and other information publicly, they are prevented from exercising their options, right? You need to do some investment 101 studying before you post these nonsensical posts. The same goes for buying additional shares. They are not allowed to act until they are no longer in possession of non-public information.

[skitahoe]

Scotty,

I believe the majority of managements warrants cannot be converted at this time and shouldn't be until the authorized shares are permitted to increase. It's true that they must either bring in cash to do so, or use the cashless option where they receive fewer shares. I believe that by the time the options are converted the share price will be so much higher that if cash is a problem, they can borrow on margin and each share will add to how much they can borrow.

Let's see what comes out at ASCO and the Annual Meeting, I believe that the shareholders will vote to authorize more shares and the share price will be high enough that it won't take that many shares to generate say $100 million.

Gary